Walter V. Klemp - Jun 16, 2022 Form 4 Insider Report for Moleculin Biotech, Inc. (MBRX)

Role
CEO and President, Director
Signature
/s/ Walter V. Klemp
Stock symbol
MBRX
Transactions as of
Jun 16, 2022
Transactions value $
-$8,097
Form type
4
Date filed
6/21/2022, 08:08 PM
Previous filing
Dec 17, 2021
Next filing
Jul 15, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MBRX Common Stock Options Exercise +25K +12.99% 217K Jun 16, 2022 Direct F1
transaction MBRX Common Stock Tax liability -$8.1K -6.09K -2.8% $1.33 211K Jun 16, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBRX Restricted Stock Units Options Exercise $0 -25K -3.57% $0.00 676K Jun 16, 2022 Common Stock 25K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
F3 On June 16, 2021, the reporting person was granted 100,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.